Millennium Shops Atherosclerosis Candidate After Positive Phase II
This article was originally published in The Pink Sheet Daily
Executive Summary
Biopharma seeks a partner before bringing the CCR2 antagonist into Phase III, firm tells “The Pink Sheet” DAILY.